drugset
drugset / Trial / NCT01182077

A Study to Assess Drug Interaction of ASP015K and Midazolam

NCT01182077 ↗

Phase 1 Completed 30 enrolled Astellas Pharma Inc
RandomizedCrossoverOpen-label

Summary

The objective of the study is to characterize the effect of multiple doses of ASP015K on the pharmacokinetics of a single dose of midazolam.

Timeline

Start
2010-06
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Midazolam Small molecule — Oral
Subject peficitinib Small molecule — Oral

Indications

No indication recorded.